Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and bismuth

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with bismuth in 2 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Studies
(bismuth)
Trials
(bismuth)
Recent Studies (post-2010) (bismuth)
25486,6626712,138

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruland, OS; Hassfjell, SP; Hoff, P1
Bruland , ØS; Hassfjell, S; Ingebrigtsen, K1

Other Studies

2 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and bismuth

ArticleYear
212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy.
    Nuclear medicine and biology, 1997, Volume: 24, Issue:3

    Topics: Alpha Particles; Animals; Bismuth; Bone and Bones; Drug Stability; Female; Femur; Lead Radioisotopes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Radioisotopes; Radiopharmaceuticals; Tissue Distribution

1997
Synthesis, purification and biodistribution of (205)Bi-DOTMP, visualizing bone deposition patterns with autoradiography.
    Nuclear medicine and biology, 2001, Volume: 28, Issue:4

    Topics: Animals; Autoradiography; Bismuth; Bone and Bones; Chromatography, High Pressure Liquid; Female; Mice; Mice, Nude; Organophosphorus Compounds; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2001